Oct. 15, 2025—HemoSonics has received FDA 510(k) clearance for expanded use of its Quantra hemostasis system with QStat cartridges in peripartum obstetric procedures. It is the first FDA-cleared viscoelastic testing platform for obstetric bleeding, according to a company press release. The system uses SEER (sonic estimation of elasticity via resonance) sonorheometry to measure the coagulation properties of a whole blood sample. It provides results in about 15 minutes.
Webinars and Sponsored Roundtables — Register Now
Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY